Please provide your email address to receive an email when new articles are posted on . The FDA approved a paclitaxel-coated balloon as an alternative treatment of coronary in-stent restenosis. The ...
Allurion Technologies, Inc ALUR recently announced three scientific presentations at the American Society for Metabolic and Bariatric Surgery Annual Meeting. One of the studies highlighted the success ...
Hosted on MSN
Cutting balloon treatment found to be 'safe and effective' for patients with calcified coronary artery disease
Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) angioplasty to intravascular lithotripsy (IVL) prior to drug‐eluting stent (DES) ...
The Company plans to submit the fourth and final module of the Pre-Market Approval application to the FDA. Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, ...
FARGO — Doctors at Essentia Health now have a new tool to assist patients with circulation issues. A "drug-coated balloon" is a promising new treatment option, and Scott Davis from Cass County was the ...
Please provide your email address to receive an email when new articles are posted on . Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary ...
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results